Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             41 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 I.3 An epigenetic mechanism for tamoxifen-associated uterine carcinogenesis? Carmichael, P.L.
 1998
 34 S4 p. S10-S11
2 p.
 artikel
2 I.5 Does the human uterus agree with existing models? Experiences with insulin-like growth factor (IGF) Tomás, E.
 1998
 34 S4 p. S12-S13
2 p.
 artikel
3 I.4 Effects of anti-oestrogens on insulin-like growth factor (IGF-I) physiology systemically and in the uterus Pollak, M.
 1998
 34 S4 p. S11-S12
2 p.
 artikel
4 I.2 From the breast to the uterus. The past and the present Neven, P.
 1998
 34 S4 p. S8-S9
2 p.
 artikel
5 II.6 Alterations in steroid hormone receptors in the tamoxifen-treated endometrium Schwartz, L.
 1998
 34 S4 p. S23-S24
2 p.
 artikel
6 III.7 Is endometrial cytology of any use? Mathelin, C.
 1998
 34 S4 p. S38-S39
2 p.
 artikel
7 III.2 Saline infusion sonography (SIS) or office hysteroscopy: Which one is the best? A prospective randomised study Timmerman, D.
 1998
 34 S4 p. S32-S33
2 p.
 artikel
8 III.5 Saline infusion sonohysterography is a good approach for additional assessment of the endometrium Neele, S.J.M.
 1998
 34 S4 p. S35-S36
2 p.
 artikel
9 II.4 Is ovarian cyst formation related to tamoxifen use? Mourits, M.J.E.
 1998
 34 S4 p. S21-S22
2 p.
 artikel
10 III.8 Tamoxifen and endometrial cancer: How should we screen? Shepherd, J.H.
 1998
 34 S4 p. S39-
1 p.
 artikel
11 III.3 Tamoxifen and endometrium: Preliminary results of a follow-up study Vosse, M.
 1998
 34 S4 p. S33-S34
2 p.
 artikel
12 III.4 Tamoxifen and the uterus: Potential uterine risks of anti-oestrogens. The approach of the European Institute Of Oncology Franchi, D.
 1998
 34 S4 p. S34-S35
2 p.
 artikel
13 III.1 Tamoxifen and the uterus—the hysteroscopic approach Van Belle, Y.
 1998
 34 S4 p. S31-S32
2 p.
 artikel
14 III.6 Tamoxifen-induced changes of the uterus: MRI features Van Hoe, L.
 1998
 34 S4 p. S36-S37
2 p.
 artikel
15 II.8 Significance of benign uterine pathology on tamoxifen Ismail, S.M.
 1998
 34 S4 p. S26-S27
2 p.
 artikel
16 II.2 Tamoxifen and benign endometrial lesions De Muylder, X.
 1998
 34 S4 p. S18-S19
2 p.
 artikel
17 II.5 Tamoxifen and other genital tissues: Vagina, cervix and ovaries Cohen, I.
 1998
 34 S4 p. S22-S23
2 p.
 artikel
18 II.3 Tamoxifen and uterine fibroids Le Bouëdec, G.
 1998
 34 S4 p. S19-S21
3 p.
 artikel
19 II.1 Tamoxifen's oestrogen-like effects in a breast cancer chemoprevention trial Powles, T.J.
 1998
 34 S4 p. S17-S18
2 p.
 artikel
20 II.7 The progestin-like activity of tamoxifen on the endometrium Dallenbach-Hellweg, G.
 1998
 34 S4 p. S24-S25
2 p.
 artikel
21 I.1 Tamoxifen and the breast Baum, M.
 1998
 34 S4 p. S7-S8
2 p.
 artikel
22 I.6 Tamoxifen metabolism and activation: the reason for interspecies differences Phillips, D.H.
 1998
 34 S4 p. S13-S14
2 p.
 artikel
23 IV.2 Does risk of endometrial cancer increase with longer duration of tamoxifen use? van Leeuwen, F.
 1998
 34 S4 p. S44-S45
2 p.
 artikel
24 IV.5 High grade endometrial cancers associated with tamoxifen use Van Hooff, I.
 1998
 34 S4 p. S48-S49
2 p.
 artikel
25 IV.4 Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case—Control study Mignotte, H.
 1998
 34 S4 p. S46-S47
2 p.
 artikel
26 IV.1 Tamoxifen, a human carcinogen or the share of common risk factors? Sasco, A.J.
 1998
 34 S4 p. S43-S44
2 p.
 artikel
27 IV.6 Tamoxifen and endometrial cancer: most cancers are early stage and highly curable Barakat, R.
 1998
 34 S4 p. S49-S50
2 p.
 artikel
28 IV.7 Tamoxifen and uterine cancer: Confounding variables Jordan, V.C.
 1998
 34 S4 p. S50-S51
2 p.
 artikel
29 IV.8 Tamoxifen to treat endometrial cancer Bonte, J.
 1998
 34 S4 p. S51-S52
2 p.
 artikel
30 IV.3 The combined effects of ERT, obesity and tamoxifen therapy for breast cancer on endometrial cancer risk Bernstein, L.
 1998
 34 S4 p. S46-
1 p.
 artikel
31 Tamoxifen and the uterus Vergote, I.
 1998
 34 S4 p. S1-S3
3 p.
 artikel
32 V.1 A randomised pilot study of hormone replacement therapy (HRT) in breast cancer patients: the combined effects of tamoxifen and HRT on the endometrium Whitehead, M.
 1998
 34 S4 p. S55-
1 p.
 artikel
33 VI.2 Cytogenetic changes in endometrial polyps from tamoxifen users Van Den Berghe, H.
 1998
 34 S4 p. S63-
1 p.
 artikel
34 VI.6 Detection of DNA adducts in the human endometrium: a lack of evidence Carmichael, P.L.
 1998
 34 S4 p. S66-S67
2 p.
 artikel
35 VI.3 DNA content in tamoxifen-induced endometrial carcinoma Moberger, B.
 1998
 34 S4 p. S64-
1 p.
 artikel
36 VI.4 Identification of tamoxifen-DNA adducts Martin, E.A.
 1998
 34 S4 p. S65-S66
2 p.
 artikel
37 V.3 Is there life after tamoxifen? New anti-oestrogens O'Regan, R.
 1998
 34 S4 p. S57-S58
2 p.
 artikel
38 VI.5 Tamoxifen-DNA adducts in breast cancer patients Hemminki, K.
 1998
 34 S4 p. S66-
1 p.
 artikel
39 VI.1 Tamoxifen-induced DNA adducts Smith, L.L.
 1998
 34 S4 p. S63-
1 p.
 artikel
40 V.4 Toremifene and the uterus Tomás, E.
 1998
 34 S4 p. S58-S59
2 p.
 artikel
41 V.2 Use of levonorgestrel intrauterine device for prevention of endometrial changes induced by tamoxifen Van Liedekerke, D.
 1998
 34 S4 p. S55-S56
2 p.
 artikel
                             41 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland